by Dr Suvadip Chakrabarti | Jun 15, 2026 | Oncology
A stage 4 cancer diagnosis no longer automatically means all treatment options are exhausted. Advances in immunotherapy, targeted therapy, robotic oncology, molecular profiling, and precision radiation have significantly changed how many advanced cancers are managed...
by Dr Suvadip Chakrabarti | May 27, 2026 | Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype that lacks common hormone and HER2 targets, making treatment more complex. It grows faster, has a higher recurrence risk, and requires carefully planned therapies. Advances in treatment are improving...
by Dr Suvadip Chakrabarti | May 12, 2026 | Oncology
Cancer is a complex disease driven by genetic mutations that cause cells to divide uncontrollably, often forming tumours and spreading metastasis (the deadliest aspect, causing over 90% of cancer-related mortality – source). It is evaluated through...
by Dr Suvadip Chakrabarti | Apr 23, 2026 | Thyroid Cancer Surgery
Papillary thyroid cancer often requires thyroidectomy with lymph node removal due to nodal spread, while follicular thyroid cancer typically involves thyroidectomy without routine lymph node dissection, focusing on vascular invasion and distant spread risk. Thyroid...
by Dr Suvadip Chakrabarti | Apr 9, 2026 | Breast Cancer
Mammograms are the standard screening tool, ultrasounds assess lumps and dense breast tissue, and MRI is reserved for high-risk or unclear cases, providing detailed imaging when other tests do not give definitive answers. Breast cancer detection isn’t a one-test game....
